Success stories Archive - Page 31 sur 45 - Prestwick Chemical Libraries

success-story

Success Stories


Publications
High-throughput fluorescence polarization assay to identify inhibitors of Cbl(TKB)-protein tyrosine kinase interactions

Analytical Biochemistry

Kumar EA, Charvet CD, Lokesh GL, Natarajan A
Analytical Biochemistry - vol. 411 254-260 (2011)

The casitas B-lineage lymphoma (Cbl) proteins play an important role in regulating signal transduction pathways by functioning as E3 ubiquitin ligases. The Cbl proteins contain a conserved tyrosine kinase binding (TKB) domain that binds more than a dozen proteins, including protein tyrosine kinases (PTKs), in a phosphorylation-dependent manner. The cell surface expression levels of the […]

Publications
Visual characterization and diversity quantification of chemical libraries: 1. Creation of delimited reference chemical subspaces

Journal of Chemical Information and Modeling

Le Guilloux V, Colliandre L, Bourg S, Guénegou G, Dubois-Chevalier J, Morin-Allory L
Journal of Chemical Information and Modeling - vol. 51 1762-1774 (2011)

High-throughput screening (HTS) is a well-established technology which can test up to several million compounds in a few weeks. Despite these appealing capabilities, available resources and high costs may limit the number of molecules screened, making diversity analysis a method of choice to design and prioritize screening libraries. With a constantly increasing number of molecules […]

Publications
Orthologue selectivity and ligand bias: Translating the pharmacology of GPR35

Trends in Pharmacological Sciences

Milligan G
Trends in Pharmacological Sciences - vol. 32 317-325 (2011)

GPR35 is a poorly characterized G protein-coupled receptor (GPCR) that has been suggested as a potential therapeutic target for the treatment of diabetes, hypertension and asthma. Two endogenously produced ligands have been suggested as activators of GPR35, although the relevance of these remains unclear. Recently, a series of surrogate agonist ligands and the first antagonists […]

Publications
Drug discovery for duchenne muscular dystrophy via utrophin promoter activation screening

PLoS ONE

Moorwood C, Lozynska O, Suri N, Napper AD, Diamond SL, Khurana TS
PLoS ONE - vol. 6 1-11 (2011)

BACKGROUND: Duchenne muscular dystrophy (DMD) is a devastating muscle wasting disease caused by mutations in dystrophin, a muscle cytoskeletal protein. Utrophin is a homologue of dystrophin that can functionally compensate for its absence when expressed at increased levels in the myofibre, as shown by studies in dystrophin-deficient mice. Utrophin upregulation is therefore a promising therapeutic […]

Publications
ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells

Biochemical and Biophysical Research Communications

Jo YK, Park SJ, Shin JH, Kim Y, Hwang JJ, Cho DH, Kim JC
Biochemical and Biophysical Research Communications - vol. 404 1039-1043 (2011)

Autophagy is a catabolic cellular process involving self-digestion and turnover of macromolecules and entire organelles. Autophagy is primarily a protective process in response to cellular stress, but it can be associated with cell death. Genetic evidence also supports autophagy function as a tumor suppressor mechanism. To identify specific regulators to autophagy, we screened the Lopac […]

Publications
Topoisomerase 1 and single-strand break repair modulate transcription-induced CAG repeat contraction in human cells

Molecular And Cellular Biology

Hubert Jr L, Lin Y, Dion V, Wilson JH
Molecular And Cellular Biology - vol. 31 3105-3112 (2011)

Expanded trinucleotide repeats are responsible for a number of neurodegenerative diseases, such as Huntington disease and myotonic dystrophy type 1. The mechanisms that underlie repeat instability in the germ line and in the somatic tissues of human patients are undefined. Using a selection assay based on contraction of CAG repeat tracts in human cells, we […]

Publications
Concurrent detection of autolysosome formation and lysosomal degradation by flow cytometry in a high-content screen for inducers of autophagy.

BMC biology

Hundeshagen P, Hamacher-Brady A, Eils R, Brady NR
BMC biology - vol. 9 38 (2011)

Autophagy mediates lysosomal degradation of cytosolic components. Recent work has associated autophagic dysfunction with pathologies, including cancer and cardiovascular disease. To date, the identification of clinically-applicable drugs that modulate autophagy has been hampered by the lack of standardized assays capable of precisely reporting autophagic activity.

Publications
Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways

Human Molecular Genetics

Takakura A, Nelson EA, Haque N, Humphreys BD, Zandi-Nejad K, Frank DA, Zhou J
Human Molecular Genetics - vol. 20 4143-4154 (2011)

Autosomal dominant polycystic kidney disease (ADPKD) is a commonly inherited disorder mostly caused by mutations in PKD1, encoding polycystin-1 (PC1). The disease is characterized by development and growth of epithelium-lined cyst in both kidneys, often leading to renal failure. There is no specific treatment for this disease. Here, we report a sustained activation of the […]

Publications
Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole.

Molecular systems biology

Spitzer M, Griffiths E, Blakely KM, Wildenhain J, Ejim L, Rossi L, De Pascale G, Curak J, Brown E, Tyers M, Wright GD
Molecular systems biology - vol. 7 499 (2011)

Resistance to widely used fungistatic drugs, particularly to the ergosterol biosynthesis inhibitor fluconazole, threatens millions of immunocompromised patients susceptible to invasive fungal infections. The dense network structure of synthetic lethal genetic interactions in yeast suggests that combinatorial network inhibition may afford increased drug efficacy and specificity. We carried out systematic screens with a bioactive library […]

Publications
GPR35 as a novel therapeutic target

Frontiers in Endocrinology

MacKenzie AE, Lappin JE, Taylor DL, Nicklin SA, Milligan G
Frontiers in Endocrinology - vol. 2 1-10 (2011)

G protein-coupled receptors (GPCRs) remain the best studied class of cell surface receptors and the most tractable family of proteins for novel small molecule drug discovery. Despite this, a considerable number of GPCRs remain poorly characterized and in a significant number of cases, endogenous ligand(s) that activate them remain undefined or are of questionable physiological […]